{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2023:3GXCNGPLGJVGE2XRS4PK2XSOPK","short_pith_number":"pith:3GXCNGPL","schema_version":"1.0","canonical_sha256":"d9ae2699eb326a626af1971ead5e4e7a84e0992406cbe096b484b63b61b49405","source":{"kind":"arxiv","id":"2302.07868","version":7},"attestation_state":"computed","paper":{"title":"Target Specific De Novo Design of Drug Candidate Molecules with Graph Transformer-based Generative Adversarial Networks","license":"http://creativecommons.org/licenses/by-nc-sa/4.0/","headline":"","cross_cats":["q-bio.BM","q-bio.QM"],"primary_cat":"cs.LG","authors_text":"Abdurrahman Ol\\u{g}a\\c{c}, Ahmet Sar{\\i}g\\\"un, Ahmet Sureyya Rifaio\\u{g}lu, Atabey \\\"Unl\\\"u, Deniz Cansen Kahraman, Elif \\c{C}evrim, Erden Bano\\u{g}lu, Hayriye \\c{C}elikbilek, Melih G\\\"okay Yi\\u{g}it, Osman Bayram, Tunca Do\\u{g}an","submitted_at":"2023-02-15T18:59:27Z","abstract_excerpt":"Discovering novel drug candidate molecules is one of the most fundamental and critical steps in drug development. Generative deep learning models, which create synthetic data given a probability distribution, offer a high potential for designing de novo molecules. However, to be utilisable in real life drug development pipelines, these models should be able to design drug like and target centric molecules. In this study, we propose an end to end generative system, DrugGEN, for the de novo design of drug candidate molecules that interact with intended target proteins. The proposed method repres"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"2302.07868","kind":"arxiv","version":7},"metadata":{"license":"http://creativecommons.org/licenses/by-nc-sa/4.0/","primary_cat":"cs.LG","submitted_at":"2023-02-15T18:59:27Z","cross_cats_sorted":["q-bio.BM","q-bio.QM"],"title_canon_sha256":"53a3fb6401a150b3add11d92eb90400242ebd420ed767c801ede42b4a70c34ba","abstract_canon_sha256":"d33a39994502ce74da998c4d6b5b147554c23d4fc89baf05f5698ba63b9d372c"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T11:09:41.266855Z","signature_b64":"zHlBbmjfKmFPstYC3oeHVta4BEeHHGpNXlDqUtlkZWdVsNzyaNrOv4r986LIIigUuaxKW5s3EArAJSgsrfisDw==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"d9ae2699eb326a626af1971ead5e4e7a84e0992406cbe096b484b63b61b49405","last_reissued_at":"2026-07-05T11:09:41.266275Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T11:09:41.266275Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Target Specific De Novo Design of Drug Candidate Molecules with Graph Transformer-based Generative Adversarial Networks","license":"http://creativecommons.org/licenses/by-nc-sa/4.0/","headline":"","cross_cats":["q-bio.BM","q-bio.QM"],"primary_cat":"cs.LG","authors_text":"Abdurrahman Ol\\u{g}a\\c{c}, Ahmet Sar{\\i}g\\\"un, Ahmet Sureyya Rifaio\\u{g}lu, Atabey \\\"Unl\\\"u, Deniz Cansen Kahraman, Elif \\c{C}evrim, Erden Bano\\u{g}lu, Hayriye \\c{C}elikbilek, Melih G\\\"okay Yi\\u{g}it, Osman Bayram, Tunca Do\\u{g}an","submitted_at":"2023-02-15T18:59:27Z","abstract_excerpt":"Discovering novel drug candidate molecules is one of the most fundamental and critical steps in drug development. Generative deep learning models, which create synthetic data given a probability distribution, offer a high potential for designing de novo molecules. However, to be utilisable in real life drug development pipelines, these models should be able to design drug like and target centric molecules. In this study, we propose an end to end generative system, DrugGEN, for the de novo design of drug candidate molecules that interact with intended target proteins. The proposed method repres"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2302.07868","kind":"arxiv","version":7},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2302.07868/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2302.07868","created_at":"2026-07-05T11:09:41.266346+00:00"},{"alias_kind":"arxiv_version","alias_value":"2302.07868v7","created_at":"2026-07-05T11:09:41.266346+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2302.07868","created_at":"2026-07-05T11:09:41.266346+00:00"},{"alias_kind":"pith_short_12","alias_value":"3GXCNGPLGJVG","created_at":"2026-07-05T11:09:41.266346+00:00"},{"alias_kind":"pith_short_16","alias_value":"3GXCNGPLGJVGE2XR","created_at":"2026-07-05T11:09:41.266346+00:00"},{"alias_kind":"pith_short_8","alias_value":"3GXCNGPL","created_at":"2026-07-05T11:09:41.266346+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/3GXCNGPLGJVGE2XRS4PK2XSOPK","json":"https://pith.science/pith/3GXCNGPLGJVGE2XRS4PK2XSOPK.json","graph_json":"https://pith.science/api/pith-number/3GXCNGPLGJVGE2XRS4PK2XSOPK/graph.json","events_json":"https://pith.science/api/pith-number/3GXCNGPLGJVGE2XRS4PK2XSOPK/events.json","paper":"https://pith.science/paper/3GXCNGPL"},"agent_actions":{"view_html":"https://pith.science/pith/3GXCNGPLGJVGE2XRS4PK2XSOPK","download_json":"https://pith.science/pith/3GXCNGPLGJVGE2XRS4PK2XSOPK.json","view_paper":"https://pith.science/paper/3GXCNGPL","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2302.07868&json=true","fetch_graph":"https://pith.science/api/pith-number/3GXCNGPLGJVGE2XRS4PK2XSOPK/graph.json","fetch_events":"https://pith.science/api/pith-number/3GXCNGPLGJVGE2XRS4PK2XSOPK/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/3GXCNGPLGJVGE2XRS4PK2XSOPK/action/timestamp_anchor","attest_storage":"https://pith.science/pith/3GXCNGPLGJVGE2XRS4PK2XSOPK/action/storage_attestation","attest_author":"https://pith.science/pith/3GXCNGPLGJVGE2XRS4PK2XSOPK/action/author_attestation","sign_citation":"https://pith.science/pith/3GXCNGPLGJVGE2XRS4PK2XSOPK/action/citation_signature","submit_replication":"https://pith.science/pith/3GXCNGPLGJVGE2XRS4PK2XSOPK/action/replication_record"}},"created_at":"2026-07-05T11:09:41.266346+00:00","updated_at":"2026-07-05T11:09:41.266346+00:00"}